These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26915853)

  • 1. Does Preoperative Beta-blocker Use Influence Intraoperative Hemodynamic Profile and Post-operative Course of Liver Transplantation?
    Milan Z; Taylor C; Armstrong D; Davies P; Roberts S; Rupnik B; Suddle A
    Transplant Proc; 2016; 48(1):111-5. PubMed ID: 26915853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
    Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J
    Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis.
    Alvarado-Tapias E; Ardevol A; Garcia-Guix M; Montañés R; Pavel O; Cuyas B; Graupera I; Brujats A; Vilades D; Colomo A; Poca M; Torras X; Guarner C; Concepción M; Aracil C; Torres F; Villanueva C
    J Hepatol; 2020 Oct; 73(4):829-841. PubMed ID: 32298768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension.
    Villanueva C; Albillos A; Genescà J; Abraldes JG; Calleja JL; Aracil C; Bañares R; Morillas R; Poca M; Peñas B; Augustin S; Garcia-Pagan JC; Pavel O; Bosch J
    Hepatology; 2016 Jan; 63(1):197-206. PubMed ID: 26422126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of the β-blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study].
    Yang S; Liu Z; Yang W; Zhang G; Hou B; Liu J; Shi Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Oct; 26(10):714-7. PubMed ID: 25315942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L; Bendtsen F; Hansen EF; Møller S
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension.
    Sekiyama T; Komeichi H; Nagano T; Ohsuga M; Terada H; Katsuta Y; Satomura K; Aramaki T
    Arzneimittelforschung; 1997 Apr; 47(4):353-5. PubMed ID: 9150854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension.
    Provencher S; Herve P; Jais X; Lebrec D; Humbert M; Simonneau G; Sitbon O
    Gastroenterology; 2006 Jan; 130(1):120-6. PubMed ID: 16401475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome.
    Blei AT; Mazhar S; Davidson CJ; Flamm SL; Abecassis M; Gheorghiade M
    J Clin Gastroenterol; 2007; 41 Suppl 3():S323-9. PubMed ID: 17975484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta-adrenergic blockade on elevated arterial compliance and low systemic vascular resistance in cirrhosis.
    Møller S; Bendtsen F; Henriksen JH
    Scand J Gastroenterol; 2001 Jun; 36(6):653-7. PubMed ID: 11424326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical modeling of hemodynamic changes during orthotopic liver transplantation: predictive value for outcome and effect of marginal donors.
    Milan Z; Taylor C; Duncan B; Kedilaya H; Sylvester D
    Transplant Proc; 2011 Jun; 43(5):1711-5. PubMed ID: 21693263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal systemic hemodynamic stability for successful clinical outcomes after adult living-donor liver transplantation: prospective observational study.
    Hori T; Yagi S; Iida T; Taniguchi K; Yamagiwa K; Yamamoto C; Hasegawa T; Yamakado K; Kato T; Saito K; Wang L; Torii M; Hori Y; Takeda K; Maruyama K; Uemoto S
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e170-8. PubMed ID: 18422962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical treatment of portal hypertension].
    Lebrec D
    Presse Med; 1991 Apr; 20(16):750-5. PubMed ID: 1675466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of carvedilol a nonselective beta-blocker on portal hemodynamics in cirrhosis.
    Fierbinteanu-Braticevici C; Udeanu M; Dragomir P; Andronescu D
    Rom J Intern Med; 2003; 41(3):247-54. PubMed ID: 15526508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J; Kravetz D; Rodes J
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
    Merkel C; Sacerdoti D; Bolognesi M; Enzo E; Marin R; Bombonato G; Angeli P; Gatta A
    Hepatology; 1997 Jul; 26(1):34-9. PubMed ID: 9214449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation.
    Giannelli V; Roux O; Laouénan C; Manchon P; Ausloos F; Bachelet D; Rautou PE; Weiss E; Moreau R; Mebazaa A; Cohen-Solal A; Durand F; Francoz C
    J Hepatol; 2020 Mar; 72(3):463-471. PubMed ID: 31622697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.